Product NDC: | 55390-258 |
Proprietary Name: | Methylprednisolone Sodium Succinate |
Non Proprietary Name: | Methylprednisolone Sodium Succinate |
Active Ingredient(s): | 500 mg/8mL & nbsp; Methylprednisolone Sodium Succinate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-258 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040709 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080108 |
Package NDC: | 55390-258-01 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (55390-258-01) > 8 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 55390-258-01 |
Proprietary Name | Methylprednisolone Sodium Succinate |
Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (55390-258-01) > 8 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 55390-258 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone Sodium Succinate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20080108 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Strength Number | 500 |
Strength Unit | mg/8mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |